Marina Bozilenko


Marina is the Head of Biotech & Pharma, Managing Director, at William Blair & Company, which she joined in 2010. She has over 25 years of investment banking and other healthcare industry expertise, including raising more than $25 billion in capital and executing numerous M&A transactions. Most recently, she was a principal at Kidd & Company, a private-equity firm, and prior to that, worked at Bear, Stearns & Co. Inc. as a senior managing director in the healthcare group. Before that, Marina was was a Managing Director and Head of Biotechnology at Bank of America Securities, and a Partner at Vector Securities International.

Marina is a Director of NeuroNetworks Fund, a non-profit organization focused on therapies for autism, epilepsy, schizophrenia and related disorders, and serves on the Advisory Board of Arctic Aurora Life Sciences, a Swedish healthcare-focused investment fund.

Marina received her B.A. in molecular biology and M.A. in economic history from the University of Chicago.